Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 4Phase 3 3Phase 2/3 2Phase NA 1Phase 4 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5Prostatic Neoplasms, Castration-Resistant 2Seizures 1Prostate Cancer Metastatic 1Primary Dysautonomias 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Kidney Diseases 1Hypertension 1Dementia 1Cognitive Dysfunction 1

Interventions

Zoledronic Acid 5Bevacizumab 3exemestane 2Therapeutics 2Standard of Care 2Pamidronate 2Oxaliplatin 2Misoprostol 2Magnetic Resonance Spectroscopy 2Letrozole 2Ibandronic Acid 2Fulvestrant 2Fluorouracil 2Cetuximab 2Capecitabine 2vandetanib 1palbociclib 1liposomal doxorubicin 1huaier 1eribulin 1enzalutamide 1darolutamide 1cabozantinib 1aldesleukin 1abemaciclib 1Vindesine 1Trastuzumab 1Sugars 1Stents 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm Metastasis × enzalutamide × Clear all
NCT02441517 2018-04-19

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Astellas Pharma Inc

Phase 4 Terminated
4 enrolled 12 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡